Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Elite Pharmaceuticals (ELTP)

OTHER OTC:ELTP

ELTP

Elite Pharmaceuticals

RESEARCH TOOLSreports

Elite Pharmaceuticals (ELTP) Ratios

Compare

373 Followers

Elite Pharmaceuticals Ratios

ELTP's free cash flow for Q3 2026 was $0.41. For the 2026 fiscal year, ELTP's free cash flow was decreased by $ and operating cash flow was $0.29. See a summary of the company’s cash flow.

Ratios	TTM	Jun 25	Jun 24	Mar 23	Mar 22
Liquidity Ratios
Current Ratio	7.34	4.88	3.07	2.75	2.82
Quick Ratio	5.44	3.50	2.08	1.53	1.81
Cash Ratio	1.60	0.96	0.54	1.00	1.28
Solvency Ratio	0.98	-0.05	0.83	369.58	1.04
Operating Cash Flow Ratio	1.40	0.63	-0.25	0.43	0.97
Short-Term Operating Cash Flow Coverage	16.58	1.76	-0.76	10.74	18.39
Net Current Asset Value	$ 50.69M	$ 14.87M	$ 13.94M	$ 9.57M	$ 8.93M
Leverage Ratios
Debt-to-Assets Ratio	0.06	0.11	0.14	0.10	0.08
Debt-to-Equity Ratio	0.09	0.20	0.20	0.13	0.11
Debt-to-Capital Ratio	0.08	0.17	0.17	0.12	0.10
Long-Term Debt-to-Capital Ratio	0.05	0.05	0.05	0.11	0.05
Financial Leverage Ratio	1.57	1.80	1.45	1.41	1.39
Debt Service Coverage Ratio	20.86	-0.28	4.54	302.38	15.08
Interest Coverage Ratio	98.11	25.38	18.33	1.82K	26.44
Debt to Market Cap	0.01	0.02	0.05	0.13	0.05
Interest Debt Per Share	<0.01	0.01	0.01	<0.01	<0.01
Net Debt to EBITDA	-0.30	-0.14	1.84	-0.61	-0.89
Profitability Margins
Gross Profit Margin	51.06%	47.70%	46.55%	48.58%	45.86%
EBIT Margin	31.29%	0.86%	1.86%	0.01%	15.72%
EBITDA Margin	32.67%	3.38%	4.46%	0.02%	20.12%
Operating Profit Margin	35.74%	23.32%	19.05%	5.93%	15.72%
Pretax Profit Margin	39.42%	-0.06%	0.82%	11.67%	22.20%
Net Profit Margin	30.98%	-5.13%	35.51%	12.91%	27.58%
Continuous Operations Profit Margin	30.98%	-5.13%	35.51%	0.01%	27.58%
Net Income Per EBT	78.59%	8275.14%	4342.25%	110.64%	124.25%
EBT Per EBIT	110.29%	-0.27%	4.29%	196.82%	141.24%
Return on Assets (ROA)	34.34%	-4.48%	24.04%	10783.21%	25.32%
Return on Equity (ROE)	71.43%	-8.06%	34.92%	15227.43%	35.28%
Return on Capital Employed (ROCE)	44.23%	23.18%	15.28%	6125.12%	17.82%
Return on Invested Capital (ROIC)	34.42%	21.87%	14.27%	6065.36%	17.48%
Return on Tangible Assets	35.94%	-4.75%	26.01%	12762.06%	31.21%
Earnings Yield	10.64%	-0.93%	12.94%	15012.72%	25.19%
Efficiency Ratios
Receivables Turnover	2.89	2.88	2.91	11.04K	10.55
Payables Turnover	10.51	14.86	11.15	7.18K	12.21
Inventory Turnover	2.73	2.71	2.34	1.84K	2.59
Fixed Asset Turnover	10.70	5.96	3.88	3.27K	4.62
Asset Turnover	1.11	0.87	0.68	835.17	0.92
Working Capital Turnover Ratio	1.77	2.31	2.79	2.64K	3.48
Cash Conversion Cycle	225.30	237.14	248.59	0.18	145.56
Days of Sales Outstanding	126.42	126.85	125.39	0.03	34.60
Days of Inventory Outstanding	133.60	134.85	155.93	0.20	140.87
Days of Payables Outstanding	34.72	24.56	32.73	0.05	29.90
Operating Cycle	260.02	261.70	281.32	0.23	175.47
Cash Flow Ratios
Operating Cash Flow Per Share	0.02	<0.01	>-0.01	<0.01	<0.01
Free Cash Flow Per Share	0.02	<0.01	>-0.01	>-0.01	<0.01
CapEx Per Share	<0.01	<0.01	<0.01	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	0.93	0.66	1.25	-0.72	0.92
Dividend Paid and CapEx Coverage Ratio	14.45	2.95	-4.05	0.58	13.05
Capital Expenditure Coverage Ratio	14.45	2.95	-4.05	0.58	13.05
Operating Cash Flow Coverage Ratio	2.57	0.68	-0.28	0.86	2.34
Operating Cash Flow to Sales Ratio	0.13	0.09	-0.06	<0.01	0.20
Free Cash Flow Yield	4.21%	1.06%	-2.63%	-8.16%	17.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	9.40	-107.70	7.73	<0.01	3.97
Price-to-Sales (P/S) Ratio	2.92	5.53	2.74	<0.01	1.09
Price-to-Book (P/B) Ratio	5.08	8.68	2.70	1.01	1.40
Price-to-Free Cash Flow (P/FCF) Ratio	23.74	94.25	-37.97	-12.25	5.88
Price-to-Operating Cash Flow Ratio	22.04	62.33	-47.34	8.80	5.43
Price-to-Earnings Growth (PEG) Ratio	0.03	0.90	-0.08	<0.01	0.06
Price-to-Fair Value	5.08	8.68	2.70	1.01	1.40
Enterprise Value Multiple	8.64	163.34	63.41	3.96	4.55
Enterprise Value	395.38M	464.31M	159.99M	25.43M	29.57M
EV to EBITDA	8.64	163.34	63.41	3.96	4.55
EV to Sales	2.82	5.52	2.83	<0.01	0.92
EV to Free Cash Flow	22.94	94.17	-39.11	-10.60	4.92
EV to Operating Cash Flow	21.35	62.28	-48.76	7.62	4.54
Tangible Book Value Per Share	0.07	0.04	0.05	0.02	0.02
Shareholders’ Equity Per Share	0.07	0.05	0.06	0.03	0.02
Tax and Other Ratios
Effective Tax Rate	0.21	-81.75	-42.42	-0.11	-0.24
Revenue Per Share	0.13	0.08	0.06	33.72	0.03
Net Income Per Share	0.04	>-0.01	0.02	4.35	<0.01
Tax Burden	0.79	82.75	43.42	1.11	1.24
Interest Burden	1.26	-0.07	0.44	781.76	1.41
Research & Development to Revenue	0.04	0.09	0.12	0.18	0.13
SG&A to Revenue	0.09	0.11	0.12	0.15	0.14
Stock-Based Compensation to Revenue	<0.01	<0.01	0.15	<0.01	0.02
Income Quality	0.43	-1.73	-0.16	0.94	0.73

Currency in USD